Phospholipids and calcium alterations in platelets of schizophrenia patients

Physiological Research

Volumn 46, Issue 1, 1997, Pages 59-68

  Ripova D ^a,b   Strunecka A ^a   Nemcova V ^a   Farska I ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

calcium; phosphoinositide; phospholipids; platelets; schizophrenia

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPID;

ARTICLE; CALCIUM HOMEOSTASIS; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; NEUROTRANSMISSION; PHOSPHOLIPID METABOLISM; REGULATORY MECHANISM; SCHIZOPHRENIA; TARGET CELL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; BLOOD PLATELETS; CALCIUM; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; HOMEOSTASIS; HUMANS; MALE; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHOLIPIDS; PYRIMIDINONES; SCHIZOPHRENIA; THROMBIN;

EID: 0030992039     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. AMERICAN PSYCHIATRIC ASSOCIATION: DSM-II-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., Washington, DC: American Psychiatric Association, 1987.
2. BERRIDGE M.J.: Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1993.
3. BERRIDGE M.J., IRVINE R.F.: Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315-321, 1984.
4. BEVERS E.M., COMFURIUS P., ZWAAL F.A.: Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 736: 57-66, 1983.
5. BITBOL M., FELLMANN P., ZACHOWSKI A., DEVAUX P.F.: Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim. Biophys. Acta 904: 268-282, 1987.
6. COCROFT S., THOMAS G.M.H.: Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem. J. 288: 1-14, 1992.
7. CORDASCO D.M., WAZER D., SEGARNICK D.J., LAUTIN A., LIPPA A., ROTROSEN J.: Phospholipids and phospholipid methylation in platelets and brain. Psychopharmacol. Bull. 18: 193-197, 1982.
8. DAS I., ESSALI M.A., DE BELLEROCHE J., HIRSCH S.R.: Inositol phospholipid turnover in platelets of schizophrenic patients. Prostaglandins Leukot. Essent. Fatty Acids 46: 65-66, 1992.
9. DEVAUX P.F., CRIBIER S., FAVRE E., FELLMANN P., SEIGNEURET M., ZACHOWSKI A.: Aminophospholipid translocation in the erythrocyte membrane is mediated by a specific ATP-dependent enzyme. In: Biomembrane and Receptor Mechanisms. E. BERTOLO, D. CHAPMAN, A. CAMBRIA, U. SCAPAGNINI (eds): Liviana Press, Padova, 1987, pp. 69-75.
10. DIXON W.J., BROWN M.B., ENGELMAN L., JENNRICH R.I.: Multiple comparison tests. In: BMDP Statistical Software Manual, W.J. DIXON (ed.), University of Carolina Press, 1992, pp. 196-200.
11. DUBOVSKY S.L., LEE CH., CHRISTIANO J., MURPHY J.: Elevated platelet intracellular calcium concentration in bipolar depression. Biol. Psychiatry 29: 444-450, 1991.
12. EICHHOLTZ T., JALINK K., FAHRENFORT I., MOOLENAAR W.H.: The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291: 677-680, 1993.
13. ESSALI M.A., DAS I., DE BELLEROCHE J., HIRSCH S.R.: The platelet polyphosphoinositide system in schizophrenia: the effects of neuroleptic treatment. Biol. Psychiatry 28: 475-487, 1990.
14. GORDESKY S.E., MARINETTI G.V.: The asymmetric arrangement of phospholipids in the human erythrocyte membrane. Biochem. Biophys. Res. Commun. 50: 1027-1031, 1973.
15. HENN F.A.: Biological concepts of schizophrenia. In: Perspectives in Schizophrenia Research. C. BAXTER, T. MELNECHUK (eds), New York: Raven Press, pp. 209-223, 1980.
16. HITZEMANN R., GARVER D.: Membrane lipids in neuropsychiatrie disorders. Psychopharmacol. Bull. 18: 190-193, 1982.
17. HITZEMANN R., HIRSCHOWITZ J., GARVER J.: Membrane abnormalities in the psychoses and affective disorders. J. Psychiatr. Res. 18: 319-326, 1984.
18. HITZEMANN R., MARK C., HIRSCHOWITZ J., GARVER D.: Characteristic of phospholipid methylation in human erythrocyte ghosts: relationship(s) to the psychoses and affective disorders. Biol. Psychiatry 20: 397-407, 1985.
19. 32P into phosphatides in slices from the guinea pig brain. J. Neurochem. 17: 357-364, 1970.
20. JOLLES J., WIRTZ K.W.A., SCHOTMAN P., GISPEN W.H.: Pituitary hormones influence polyphosphoinositide metabolism in rat brain. FEBS Lett. 105: 110-114, 1979.
21. KAIYA H.: Second messenger imbalance hypothesis of schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 46: 33-38, 1992.
22. KAIYA H., NISHIDA A., IMAI A., NAKASHIMA S., NOZAWA Y.: Accumulation of diacylglycerol in platelet phosphoinositide turnover in schizophrenia: a biological marker of good prognosis? Biol. Psychiatry 26: 669-676, 1989.
23. KESHAVAN M.S., MALLINGER A.G., PETTEGREW J.W., DIPPOLD C.: Erythrocyte membrane phospholipids in psychotic patients. Psychiatr. Res. 49: 89-95, 1993.
24. LAPETINA E.G.: Metabolism of inositides and the activation of platelets. Life Sci. 32: 2069-2084, 1983.
25. LAUTIN A., CORDASCO D.M., SEGARNICK D.J., WOOD L., MASON M.F., WOLKIN A., ROTROSEN J.: Red cell phospholipids in schizophrenia. Life Sci 31: 3051-3056, 1982.
26. LE QUAN SANG K.H., MIGNOT E., GILBERT J.C., HUGUET R., AQUINO J.P., REGNIER O., DEVYNCK M.A.: Platelet cytosolic free-calcium concentration is increased in aging and Alzheimers's disease. Biol. Psychiatry 33: 391-393, 1993.
27. LOWRY O.H., ROSENBROUGH N.J., FARR A.L., RANDALL R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 192: 265-275, 1951.
28. OROLOGAS A.G., BUCKMAN T.D., EIDUSON S.: A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls. Neurosci. Lett. 68: 299-304, 1986.
29. PANGERL A.M., STEUDLE A., JARONI H.W., RUFER R., GATTAZ W.F.: Increased platelet membrane lysophosphatidylcholine in schizophrenia. Biol. Psychiatry 30: 837-840, 1991.
30. 2+. Biosci. Rep. 7: 81-91, 1987.
31. RANA R.S., HOKIN L.E.: Role of phosphoinositides in transmembrane signalling. Physiol. Rev. 70: 115-164, 1990.
32. RINK T.J., HALLAM T.J.: What turns platelet on? Trends Biochem. Sci. 9: 215-219, 1984.
33. RITTENHOUSE S.E.: Inositol lipid metabolism in the responses of stimulated platelets. Cell Calcium 3: 311-322, 1982.
34. ROTROSEN J., WOLKIN A.: Phospholipid and prostaglandin hypotheses of schizophrenia. In: Psychopharmacology: The Third Generation of Progress, H.Y. MELTZER (ed.), Raven Press New York, 1987, pp. 759-764.
35. SENGUPTA N., DATTA S.C., SENGUPTA D.: Platelet erythrocyte membrane lipid and phospholipid patterns in different types of mental patients. Biochem. Med. 25: 267-275, 1981.
36. SHERMAN W.R., LEAVITT A.L., HONCHAR M.P., HALLCHER L.M., PHILLIPS B.E.: Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat. J. Neurochem. 36: 1947-1951, 1981.
37. SCHROIT A.J., ZWAAL R.F.A.: Transbilayer movement of phospholipids in red blood cell and platelet membranes. Biochim. Biophys. Acta 1071: 313-329, 1991.
38. SIESS W.: Multiple signal-transduction pathways synergize in platelet activation. News Physiol. Sci. 6: 51-56, 1991.
39. STEVENS J.D.: The distribution of the phospholipid fractions in the red cell membrane of schizophrenics. Schizophr. Bull. 6: 60-61, 1972.
40. STRUNECKÁ A., FOLK P.: Calcium affects phosphoinositide turnover in human erythrocytes. Gen. Physiol. Biophys. 9: 281-290, 1990.
41. STRUNECKÁ A., KRPEJŠOVÁ L., PALEČEK J., MÁCHA J., MATUROVÁ M., ROSA J., PALEČKOVÁ A.: Transbilayer redistribution of phosphatidylserine in erythrocytes of a patient with autoerythrocyte sensitization syndrome (psychogenic purpura). Folia Haematol. 117: 829-841, 1990.
42. STRUNECKÁ A., ŘÍPOVÁ D., FOLK P.: Effect of chlorpromazine on inositol-lipid signalling system in human thrombocytes. Physiol. Bohemoslov. 36: 495-501, 1987.
43. TANDON R., GREDEN J.F.: Abnormal phosphoinositide turnover in schizophrenia. Biol. Psychiatry 29: 295-296, 1991.
44. TERSTAPPEN M.H., THOMPSON W. (eds.) : Clinical Applications of Flow Cytometry. ASCP National Meeting-Fall, 1991, pp. 1-145.
45. TOLBERT L.C., MONTI J.A., O'SHIELDS H., WALTER-RYAN W., MEADOWS D., SMYTHIES J.R.: Defects in transmethylation and membrane lipids in schizophrenia. Psychopharmacol. Bull. 19: 594-599, 1983.
46. WILLIAMSON P., SCHLEGEL R.: Maintenance of phospholipid asymmetry and its role in erythrocyte pathology. In: Erythrocyte Membranes 3: Recent Clinical and Experimental Advances, A.R. LISS (ed.), New York, 1984, pp. 123-136.
47. YAO J.K., YASAEI P., VAN KAMMEN D.P.: Increased turnover of platelet phosphatidylinositol in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 46: 39-46, 1992.
48. ZACHOWSKI A.: Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem. J. 294: 1-14, 1993.